The earliest changes happen in the brain stem, often years before symptoms appear

Parkinson's disease begins with the loss of nerve cells that produce dopamine, a chemical messenger the brain uses to control movement. This loss typically starts in a region called the substantia nigra, deep in the brain stem. The cell death is gradual—sometimes so gradual that a person has lost 50 to 60 percent of these dopamine-producing cells before they notice anything wrong.

The reason the disease progresses silently at first is that the brain has some capacity to compensate. Remaining cells work harder and produce more dopamine to make up for the ones that are gone. But once the loss crosses a threshold—usually around that 50 percent mark—the brain can no longer keep up, and motor symptoms become noticeable. This is why people often say their symptoms appeared suddenly, even though the underlying damage began years earlier.

Researchers have found that the cell death may start even before the brain stem is affected. Some evidence suggests changes begin in the gut or the olfactory nerve (the one that carries smell signals to the brain), then spread upward over time. This is still an area of active research, and the exact sequence varies from person to person.

Key Takeaways

  • Parkinson's begins with the death of dopamine-producing nerve cells in the brain stem, a process that can take years before any symptoms show.
  • The brain compensates for cell loss until roughly half the dopamine-producing cells are gone, which is when movement problems typically become noticeable.
  • Cell death may originate in the gut or smell nerve and spread to the brain over time, though the exact starting point differs among individuals.
  • Protein clumps called Lewy bodies accumulate inside nerve cells and are thought to drive the cell death, but why this happens remains unclear.

What role do protein clumps play

Inside the dying nerve cells, researchers find abnormal clumps of a protein called alpha-synuclein. These clumps, called Lewy bodies, appear to be a hallmark of Parkinson's disease. They accumulate inside cells and are believed to interfere with how the cell functions, eventually leading to cell death.

The exact mechanism is still being worked out. One leading theory is that alpha-synuclein proteins misfold—they twist into the wrong shape—and then stick together like a chain of misshapen links. These clumps may block the cell's ability to produce energy, damage its internal structures, or trigger the cell to self-destruct. What is not yet clear is why this protein misfolding happens in the first place, or why it happens in some people and not others.

Interestingly, Lewy bodies are not unique to Parkinson's. They also appear in other conditions like Lewy body dementia and some cases of Alzheimer's disease. This suggests that alpha-synuclein misfolding may be a common pathway in several neurodegenerative diseases, but something about Parkinson's disease makes the dopamine cells particularly vulnerable.

Genetic and environmental factors that may increase risk

About 10 to 15 percent of people with Parkinson's have a family history of the disease, suggesting that inherited genes play a role in some cases. Researchers have identified several genes—including SNCA, LRRK2, and PINK1—where mutations increase the risk of developing Parkinson's. People who carry these mutations do not always develop the disease, which means genes are part of the picture but not the whole story.

Environmental exposures may also contribute. Pesticide exposure, particularly to herbicides and insecticides, has been linked to higher Parkinson's risk in some studies. Repeated head injuries, especially in athletes or military personnel, have also been associated with earlier onset. Living in rural areas, where pesticide use is more common, shows a higher disease rate than urban areas in some research.

Most people with Parkinson's have no family history and no obvious environmental exposure. This suggests that the disease usually results from a combination of factors—perhaps a genetic predisposition that only becomes a problem when combined with a specific environmental trigger, or simply the accumulated wear on the brain over decades of life. The interplay between genes and environment remains one of the major unsolved questions in Parkinson's research.

Why dopamine loss affects movement specifically

Dopamine is not just one chemical with one job. It is used throughout the brain for different functions. In Parkinson's disease, the cells that die are concentrated in the substantia nigra, a region that controls the initiation and smoothness of movement. This is why the earliest symptoms are almost always movement-related: tremor, stiffness, or slowness.

The substantia nigra sends dopamine signals to another brain region called the striatum, which acts like a relay station for movement commands. When dopamine levels drop, the striatum cannot properly filter and coordinate the signals coming from other parts of the brain. The result is the characteristic symptoms of Parkinson's—a tremor at rest, muscles that feel rigid, and difficulty starting or speeding up movements.

As the disease progresses and dopamine loss spreads to other brain regions, non-movement symptoms can develop: depression, cognitive changes, sleep problems, and autonomic dysfunction (problems with blood pressure, digestion, or temperature control). This is why later-stage Parkinson's affects so much more than movement alone.

How the disease spreads through the brain

One of the most striking discoveries in recent Parkinson's research is that the disease does not affect all brain regions at once. Instead, it appears to spread in a pattern, with Lewy bodies and cell death appearing in some areas before others. This observation has led to the Braak hypothesis, a model suggesting that pathology starts in the lower brain stem or gut and gradually spreads upward to affect higher brain regions over years or decades.

If this model is correct, it would explain why symptoms progress in a somewhat predictable order: movement problems first, then cognitive and mood changes later. It would also suggest that the disease is not simply a random degeneration but a process that advances along specific neural pathways. Some researchers are exploring whether stopping the spread early—before it reaches the dopamine cells—might prevent or delay symptoms.

However, not all cases follow this pattern exactly. Some people show Lewy bodies in multiple brain regions at once, and the relationship between where Lewy bodies are found and what symptoms a person experiences is not always straightforward. This variation is one reason why Parkinson's affects different people so differently.

What we still do not know about disease onset

Despite decades of research, fundamental questions remain unanswered. Why does alpha-synuclein start to misfold in the first place? Why are some people's brains able to tolerate Lewy bodies without developing symptoms, while others develop severe disease? Why do some people develop Parkinson's at 40 and others at 80, even if they carry the same genetic mutations?

Researchers are pursuing several promising leads. Some are studying whether infections, inflammation, or problems with the brain's waste-clearing system might trigger or accelerate the disease. Others are investigating whether the gut microbiome—the bacteria living in the digestive tract—plays a role, since some evidence suggests the disease may originate there. Still others are looking at whether mitochondria, the energy-producing structures inside cells, fail in ways that make dopamine cells particularly vulnerable.

The lack of a complete picture means that predicting who will develop Parkinson's remains difficult, and preventing the disease before symptoms appear is not yet possible. However, understanding the early stages of the disease is a necessary step toward both prevention and early intervention.

Frequently Asked Questions

Can Parkinson's disease be prevented if you know it runs in your family?

There is no proven way to prevent Parkinson's disease, even if you carry a genetic risk. However, some research suggests that regular exercise, a Mediterranean-style diet, and avoiding pesticide exposure may reduce risk. If you have a family history, discussing your risk with a neurologist can help you understand what to watch for and when to seek evaluation.

Does having Lewy bodies in your brain mean you will definitely develop Parkinson's?

No. Autopsy studies have found Lewy bodies in the brains of some people who never had Parkinson's symptoms during life. This suggests that the presence of these protein clumps alone is not sufficient to cause disease—other factors, such as how widespread the damage is or which brain regions are affected, also matter.

Why do some people get Parkinson's at a young age and others much later?

The rate at which dopamine cells die varies greatly between individuals. Genetic factors, environmental exposures, and possibly differences in how well the brain can compensate for cell loss all play a role. Young-onset Parkinson's (before age 50) is more likely to be linked to inherited genetic mutations, while late-onset disease is usually multifactorial.

If I have a tremor or stiffness, does that mean I am developing Parkinson's?

Tremor and stiffness have many causes—thyroid problems, medication side effects, essential tremor, and other conditions can produce similar symptoms. Only a neurologist can determine whether symptoms are due to Parkinson's disease or something else. If you notice new movement changes, seeing a doctor is the appropriate next step.